# Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients

> **NCT00799838** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 106 (actual)

## Conditions studied

- Pharyngotonsillitis

## Interventions

- **DRUG:** Ketoprofen
- **DRUG:** Placebo (for Ketoprofen)
- **DRUG:** Amoxicillin

## Key facts

- **NCT ID:** NCT00799838
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 106 (ACTUAL)
- **Why stopped:** Recruitment challenges despite several attenpts to increase enrollment
- **Last updated:** 2014-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799838, "Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00799838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*